Amazon (AMZN) gave Wall Street a lot to like, and BofA analysts have responded in kind. The bank kept its buy rating on Amazon stock, while raising its price target to $310 from $298, implying Read more…
Declining furniture sales, as a result of a multi-year housing slump, and rising product and labor costs driven by inflation and higher tariffs, have been blamed for a reduction in furniture company sales and profits over the Read more…
TheStreet aims to feature only the best products and services. If you buy something via one of our links, we may earn a commission. Why we love this deal When you’re out and about, there’s Read more…
There is not a publicly traded company in America quite like this one right now. It is the only stock where the President of the United States logs onto social media to congratulate the country Read more…
While it’s not attributed to any specific person, there’s a legendary quote that’s meant to sum up the challenges of owning a boat. “The two best days in a boat owner’s life are the day Read more…
Most investors see a stock drop 13% after a bad earnings report and walk away. One of the most closely watched portfolio managers in the market saw the same setup and moved in the opposite Read more…
McDonald’s has long relied on high-profile collaborations to stay culturally relevant and drive consumer engagement across generations. From celebrity partnerships to limited-edition Happy Meals, these initiatives have become a major part of the company’s marketing strategy. Read more…
McDonald’s most impressive feat is not that it rose to the top of the fast-food chain; it’s that it managed to stay there. The chain was founded in 1940, but its true rise to prominence Read more…
For most of 2026, General Motors (GM) has been a stock that makes investors nervous. From tariff headlines, EV restructuring charges, a war in the Middle East pushing up raw material costs, and a share Read more…
Eli Lilly’s first-quarter report gave Wall Street another reason to stay optimistic about one of the market’s biggest pharmaceutical winners, even as analysts continue to weigh how much growth is already priced into the stock. Read more…